Epigenetic silencing of claudin-6 promoted anchorage-independent growth, cellular invasiveness and transendothelial migration of breast carcinoma cells, accompanied by an increase in matrix metalloproteinase activity[38]. The gene discussed is CLDN6; the disease is breast carcinoma.